During the past decade, Cardiologicum Dresden und Pirna conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiologicum Dresden und Pirna" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials sponsored, "GWT-TUD GmbH" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiologicum Dresden und Pirna" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "University of Leipzig" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiologicum Dresden und Pirna" are "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Hypercholesterolemia" (2 trials), "Obstructive Hypertrophic Cardiomyopathy" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Cardiologicum Dresden und Pirna" in a lesser frequency.

Most popular intervention types in "Cardiologicum Dresden und Pirna" are "Drug" (11 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "mavacamten" (2 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiologicum Dresden und Pirna" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Cardiologicum Dresden und Pirna". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Cardiologicum Dresden und Pirna, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiologicum Dresden und Pirna, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".